Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer
Public ClinicalTrials.gov record NCT01109524. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Cisplatin and Vinorelbine in Combination With Cetuximab as First Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC): a Single Arm Multicenter Safety Phase 2 Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to determine if U.S. manufactured Cetuximab can be safely used for the treatment of Non-Small Cell Lung Cancer in combination with Cisplatin and Vinorelbine.
Study identification
- NCT ID
- NCT01109524
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 72 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2010
- Primary completion
- Aug 31, 2012
- Completion
- Aug 31, 2012
- Last update posted
- Dec 23, 2015
2010 – 2012
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Donald W. Hill M.D., P.C. | Casa Grande | Arizona | 85122 | — |
| Beverly Hills Cancer Center | Beverly Hills | California | 90211 | — |
| Cancer Care Institute | Los Angeles | California | 90036 | — |
| Northern California Hematology & Oncology | Oakland | California | 94609 | — |
| Sharp Clinical Oncology Research | San Diego | California | 92123 | — |
| Broward Oncology Associates, P.A. | Fort Lauderdale | Florida | 33308 | — |
| Elite Research Institute | Miami | Florida | 33125 | — |
| Edward H. Kaplan, MD & Associates | Skokie | Illinois | 60076 | — |
| Fairview Southdale Medical Oncology Clinic | Edina | Minnesota | 55435 | — |
| Mid Dakota Clinic, Pc | Bismarck | North Dakota | 58501 | — |
| Temple University Hospital | Philadelphia | Pennsylvania | 19140 | — |
| University Medical Center | Lubbock | Texas | 79415 | — |
| Columbia Basin Hematology and Oncology | Kennewick | Washington | 99336 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01109524, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 23, 2015 · Synced Sep 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01109524 live on ClinicalTrials.gov.